{"id":"https://openalex.org/W3142931815","doi":"https://doi.org/10.1016/j.pupt.2021.102030","title":"The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant","display_name":"The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant","alternate_titles":[],"publication_year":2021,"publication_date":"2021-04-04","ids":{"openalex":"https://openalex.org/W3142931815","doi":"https://doi.org/10.1016/j.pupt.2021.102030","mag":"3142931815","pmid":"https://pubmed.ncbi.nlm.nih.gov/33826946"},"language":"en","primary_location":{"id":"doi:10.1016/j.pupt.2021.102030","doi":"https://doi.org/10.1016/j.pupt.2021.102030","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pupt.2021.102030","pdf_url":null,"source":{"id":"https://openalex.org/S102131606","display_name":"Pulmonary Pharmacology & Therapeutics","issn_l":"1094-5539","issn":["1094-5539","1522-9629"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3142931815"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pure.eur.nl/en/publications/ab3bdce6-c68e-4aeb-92b5-d681d45e2f52","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048320859","display_name":"Christopher Edward Brightling","orcid":"https://orcid.org/0000-0002-9345-4903","observed_orcids":["https://orcid.org/0000-0002-9345-4903"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]},{"id":"https://openalex.org/I4210166781","display_name":"NIHR Leicester Biomedical Research Centre","ror":"https://ror.org/05xqxa525","country_code":"GB","type":"facility","lineage":["https://openalex.org/I143804889","https://openalex.org/I153648349","https://openalex.org/I2802445252","https://openalex.org/I34931013","https://openalex.org/I4210166781"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Chris Brightling","raw_affiliation_strings":["Department of Respiratory Science, NIHR Biomedical Research Centre, Institute for Lung Health University of Leicester, Leicester, LE3 9QP, UK. Electronic address: ceb17@leicester.ac.uk","Department of Respiratory Science, NIHR Biomedical Research Centre, Institute for Lung Health University of Leicester, Leicester, LE3 9QP, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Science, NIHR Biomedical Research Centre, Institute for Lung Health University of Leicester, Leicester, LE3 9QP, UK. Electronic address: ceb17@leicester.ac.uk","institution_ids":["https://openalex.org/I153648349","https://openalex.org/I4210166781"]},{"raw_affiliation_string":"Department of Respiratory Science, NIHR Biomedical Research Centre, Institute for Lung Health University of Leicester, Leicester, LE3 9QP, UK","institution_ids":["https://openalex.org/I153648349","https://openalex.org/I4210166781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086883657","display_name":"Swarupa G. Kulkarni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Swarupa Kulkarni","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078648107","display_name":"Bart N. Lambrecht","orcid":"https://orcid.org/0000-0003-4376-6834","observed_orcids":["https://orcid.org/0000-0003-4376-6834"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I32597200","display_name":"Ghent University","ror":"https://ror.org/00cv9y106","country_code":"BE","type":"education","lineage":["https://openalex.org/I32597200"]},{"id":"https://openalex.org/I4210139803","display_name":"VIB-UGent Center for Inflammation Research","ror":"https://ror.org/04q4ydz28","country_code":"BE","type":"facility","lineage":["https://openalex.org/I2802017950","https://openalex.org/I32597200","https://openalex.org/I4210139803"]}],"countries":["BE","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bart N. Lambrecht","raw_affiliation_strings":["Laboratory of Immunoregulation, VIB Center for Inflammation Research, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands","Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium","Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands","Laboratory of Immunoregulation, VIB Center for Inflammation Research, Ghent, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Immunoregulation, VIB Center for Inflammation Research, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I32597200","https://openalex.org/I4210139803"]},{"raw_affiliation_string":"Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium","institution_ids":["https://openalex.org/I32597200"]},{"raw_affiliation_string":"Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]},{"raw_affiliation_string":"Laboratory of Immunoregulation, VIB Center for Inflammation Research, Ghent, Belgium","institution_ids":["https://openalex.org/I4210139803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000212406","display_name":"David A. Sandham","orcid":"https://orcid.org/0000-0003-4523-9931","observed_orcids":["https://orcid.org/0000-0003-4523-9931"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Sandham","raw_affiliation_strings":["Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA"],"raw_orcid":"https://orcid.org/0000-0003-4523-9931","affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067468660","display_name":"H. Weiss","orcid":"https://orcid.org/0000-0003-0280-4814","observed_orcids":["https://orcid.org/0000-0003-0280-4814"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Markus Weiss","raw_affiliation_strings":["Novartis Institutes for Biomedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for Biomedical Research, Fabrikstrasse 2, Novartis Campus, CH-4056, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001667913","display_name":"Pablo Altman","orcid":"https://orcid.org/0000-0002-4799-903X","observed_orcids":["https://orcid.org/0000-0002-4799-903X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pablo Altman","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA"],"raw_orcid":"https://orcid.org/0000-0002-4799-903X","affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5048320859"],"corresponding_institution_ids":["https://openalex.org/I153648349","https://openalex.org/I4210166781"],"apc_list":{"value":2960,"currency":"USD","value_usd":2960},"apc_paid":null,"fwci":0.3272,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.33236152,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"68","issue":null,"first_page":"102030","last_page":"102030"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fevipiprant","display_name":"fevipiprant","score":1.0},{"id":"https://openalex.org/keywords/prostaglandin-d2-receptor","display_name":"prostaglandin D2 receptor","score":0.8889999985694885},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6610000133514404},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9649999737739563},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.8939999938011169},{"id":"https://openalex.org/keywords/sputum-eosinophilia","display_name":"sputum eosinophilia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6467711925506592},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5395429134368896},{"id":"https://openalex.org/C2777361909","wikidata":"https://www.wikidata.org/wiki/Q419750","display_name":"Prostaglandin D2","level":3,"score":0.5073851943016052},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45103275775909424},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4483559727668762},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42463168501853943},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.36734920740127563},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32464030385017395},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3213171362876892}],"mesh":[{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007113","descriptor_name":"Immunity, Innate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007210","descriptor_name":"Indoleacetic Acids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011453","descriptor_name":"Prostaglandins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1016/j.pupt.2021.102030","doi":"https://doi.org/10.1016/j.pupt.2021.102030","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pupt.2021.102030","pdf_url":null,"source":{"id":"https://openalex.org/S102131606","display_name":"Pulmonary Pharmacology & Therapeutics","issn_l":"1094-5539","issn":["1094-5539","1522-9629"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:33826946","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33826946","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary pharmacology & therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:archive.ugent.be:8712024","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1854/LU-8712024","pdf_url":null,"source":{"id":"https://openalex.org/S4306400478","display_name":"Ghent University Academic Bibliography (Ghent University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32597200","host_organization_name":"Ghent University","host_organization_lineage":["https://openalex.org/I32597200"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ISSN: 1094-5539","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire/ab3bdce6-c68e-4aeb-92b5-d681d45e2f52","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/ab3bdce6-c68e-4aeb-92b5-d681d45e2f52","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brightling, C, Kulkarni, S, Lambrecht, B N, Sandham, D, Weiss, M & Altman, P 2021, 'The pharmacology of the prostaglandin D 2 receptor 2 (DP 2 ) receptor antagonist, fevipiprant', Pulmonary Pharmacology and Therapeutics, vol. 68, 102030. https://doi.org/10.1016/j.pupt.2021.102030","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:eur:oai:pure.eur.nl:publications/ab3bdce6-c68e-4aeb-92b5-d681d45e2f52","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/ab3bdce6-c68e-4aeb-92b5-d681d45e2f52","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pulmonary Pharmacology and Therapeutics, 68:102030. Academic Press","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:oai:oak.novartis.com:44241","doi":null,"is_oa":true,"landing_page_url":"https://reader.elsevier.com/reader/sd/pii/S1094553921000420?token=019F7F431F4E66DB1EE9148958FDA98F4E2545DD0AF7325C5C47EE059D055900DA8BC911A0513D6EE789B9C73D2CF394&originRegion=us-east-1&originCreation=20210608145303","pdf_url":null,"source":{"id":"https://openalex.org/S4306400709","display_name":"The Novartis Repository (Novartis)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1283582996","host_organization_name":"Novartis (Switzerland)","host_organization_lineage":["https://openalex.org/I1283582996"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:pure.eur.nl:openaire/ab3bdce6-c68e-4aeb-92b5-d681d45e2f52","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/ab3bdce6-c68e-4aeb-92b5-d681d45e2f52","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brightling, C, Kulkarni, S, Lambrecht, B N, Sandham, D, Weiss, M & Altman, P 2021, 'The pharmacology of the prostaglandin D 2 receptor 2 (DP 2 ) receptor antagonist, fevipiprant', Pulmonary Pharmacology and Therapeutics, vol. 68, 102030. https://doi.org/10.1016/j.pupt.2021.102030","raw_type":"info:eu-repo/semantics/review"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W1483555207","https://openalex.org/W1491383197","https://openalex.org/W1680932833","https://openalex.org/W1907278795","https://openalex.org/W1969324457","https://openalex.org/W1980109320","https://openalex.org/W1982158616","https://openalex.org/W1984212762","https://openalex.org/W1985242752","https://openalex.org/W1988758075","https://openalex.org/W1990975659","https://openalex.org/W1991225939","https://openalex.org/W1994424025","https://openalex.org/W2030571587","https://openalex.org/W2033050749","https://openalex.org/W2046222341","https://openalex.org/W2051693683","https://openalex.org/W2060277916","https://openalex.org/W2070235550","https://openalex.org/W2084624382","https://openalex.org/W2095754126","https://openalex.org/W2097096084","https://openalex.org/W2106790228","https://openalex.org/W2111015948","https://openalex.org/W2117254494","https://openalex.org/W2125660522","https://openalex.org/W2128382611","https://openalex.org/W2129935236","https://openalex.org/W2130414223","https://openalex.org/W2139123455","https://openalex.org/W2140688081","https://openalex.org/W2141495549","https://openalex.org/W2156797817","https://openalex.org/W2160134481","https://openalex.org/W2160634538","https://openalex.org/W2162392926","https://openalex.org/W2163870925","https://openalex.org/W2166893697","https://openalex.org/W2169506749","https://openalex.org/W2289369304","https://openalex.org/W2297115086","https://openalex.org/W2313856416","https://openalex.org/W2340322984","https://openalex.org/W2416670679","https://openalex.org/W2475158269","https://openalex.org/W2475880293","https://openalex.org/W2576968561","https://openalex.org/W2594033175","https://openalex.org/W2608159180","https://openalex.org/W2608523805","https://openalex.org/W2744177930","https://openalex.org/W2745578669","https://openalex.org/W2773377402","https://openalex.org/W2774440400","https://openalex.org/W2801098655","https://openalex.org/W2807891717","https://openalex.org/W2885211253","https://openalex.org/W2891161399","https://openalex.org/W2894457700","https://openalex.org/W2899263621","https://openalex.org/W2902819785","https://openalex.org/W2904271127","https://openalex.org/W2911828074","https://openalex.org/W2920733092","https://openalex.org/W2951908116","https://openalex.org/W2954440549","https://openalex.org/W2990330529","https://openalex.org/W2990469850","https://openalex.org/W2991126511","https://openalex.org/W2996811709","https://openalex.org/W3046257553","https://openalex.org/W3088941521","https://openalex.org/W4211175431","https://openalex.org/W6639960545","https://openalex.org/W6680994101","https://openalex.org/W6683145449","https://openalex.org/W6746224519","https://openalex.org/W6746676663","https://openalex.org/W6770636534","https://openalex.org/W7000604605"],"related_works":["https://openalex.org/W2954440549","https://openalex.org/W3015142399","https://openalex.org/W2987977290","https://openalex.org/W2906424847","https://openalex.org/W2990469850","https://openalex.org/W6901619344","https://openalex.org/W2745578669","https://openalex.org/W2990330529","https://openalex.org/W3189069311","https://openalex.org/W2908121480"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3142931815","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-04-13T00:00:00"}
